Clinical Trial Update: Cytosponge™ for Post-Chemoradiation Surveillance of Oesophageal Cancer [NA]

View source ↗

Summary

A completed clinical trial evaluating Cytosponge™ for post-chemoradiation surveillance in oesophageal cancer; results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Oesophageal Cancer

Drugs mentioned

• Cytosponge

Snippet

Sponsor: University of Oxford | Conditions: Oesophageal Cancer | NA | Status: COMPLETED | Results posted: 2022-07-25